Suchergebnisse - "*Ritonavir"

PubPharm (8)

1

Cryptococcal meningitis and immune reconstitution inflammatory syndrome in a pediatric patient with HIV after switching to second line antiretroviral therapy : a case report

enthalten in: BMC infectious diseases | 2020

von Otto, S. | George, P. | Mercedes, R. | +1

2

Comparative efficacy and safety of dolutegravir relative to common core agents in treatment-naïve patients infected with HIV-1 : a systematic review and network meta-analysis

enthalten in: BMC infectious diseases | 2019

von Snedecor, S. | Radford, M. | Kratochvil, D. | +2

3

Improvement of lipid profile after switching from efavirenz or ritonavir-boosted protease inhibitors to rilpivirine or once-daily integrase inhibitors : results from a large observational cohort study (SCOLTA)

enthalten in: BMC infectious diseases | 2018

von Taramasso, L. | Tatarelli, P. | Ricci, E. | +56

4

Efficacy and safety of abacavir-containing combination antiretroviral therapy as first-line treatment of HIV infected children and adolescents : a systematic review and meta-analysis

enthalten in: BMC infectious diseases | 2015

von Adetokunboh, O. | Schoonees, A. | Balogun, T. | +1

5

Comparative impact of antiretroviral drugs on markers of inflammation and immune activation during the first two years of effective therapy for HIV-1 infection : an observational study

enthalten in: BMC infectious diseases | 2014

von Hattab, S. | Guihot, A. | Guiguet, M. | +7

6

Evaluation of cardiovascular biomarkers in a randomized trial of fosamprenavir/ritonavir vs. efavirenz with abacavir/lamivudine in underrepresented, antiretroviral-naïve, HIV-infected patients (SUPPORT) : 96-week results

enthalten in: BMC infectious diseases | 2013

von Kumar, P. | DeJesus, E. | Huhn, G. | +10

7

Rate and determinants of treatment response to different antiretroviral combination strategies in subjects presenting at HIV-1 diagnosis with advanced disease

enthalten in: BMC infectious diseases | 2011

von Esposito, A. | Floridia, M. | d'Ettorre, G. | +7

8

Combination antiretroviral drugs in PLGA nanoparticle for HIV-1

enthalten in: BMC infectious diseases | 2009

von Destache, C. | Belgum, T. | Christensen, K. | +3

1
[1]